The 16th International Conference on Behçet’s Disease will take place from 18 to 20 September 2014, in Paris, France.
As the main event in the world of Behçet’s Disease, the Conference will provide high quality contributions on a wide range of topics including clinical innovations, genetics and basic science. Update on new therapeutic strategies will be presented and challenging issues will be discussed. We have planned to invite distinguished lecturers notably in the field of innate immunity.
To make this Conference the most interactive, we will organize breakfast meetings that will be an opportunity for sharing experiences with experts. As the last Conference in Paris was held in 1993, we are honoured to welcome you again in the “City of Light” and we wish your stay being instructive and enjoyable.
Welcome in Paris.
Pr Isabelle Koné-Paut, Paris
Pr Bahram Bodaghi, Paris
16th International Conference on Behçet s Disease
Cité Internationale Universitaire de Paris *Paris, FRANCE Visit the Venue to read more
Please note that abstracts will be submitted with author indicating preference for Free Paper or Poster presentation, but the committee will determine the presentation method. Authors will be informed of acceptance or rejection of submission by the Scientific Program Committee.
Please note that your abstract will be accepted and submitted to the jury only after your registration to the congress (opening on January 2nd, 2014).
PROCEDURE FOR THE SUBMISSION OF ABSTRACTS
Each individual may submit only one abstract as presenting author for a free paper at the congress.
DEADLINE: May 1st, 2014.
Submit your abstract
You will receive a confirmation of your registration in the software system and your password by email.
Enter the following information:
• Authors (The first author listed should be the presenter).
• Affiliations of Authors (e.g., University of Valencia, Valencia, Spain)
• Presentation Type
Enter the body of the abstract.
Abstracts for papers and posters should be organized as follows:
• Materials and Methods
Do not include any figures, tables, charts, references or illustrations. All abstracts must not exceed 250 words in length for the body text and written in English. The title of the subject should be within 20 words in English.
Abstract submissions can only be made electronically through the congress website. The ID Number is generated when an abstract is submitted. During the submission period, you may edit your abstract with this ID number and the password. Please retain them for future reference.
After the deadline for abstract submission, any change related to abstracts cannot be made. Please make sure all the submitted information is accurate before the deadline.
Questions regarding the abstract submission process should be directed to: email@example.com
By submitting the abstract, the author confirms and agrees to the following:
All authors approve submitting this work for presentation.
The authors have done the work reported in the abstract and take full responsibility for the contents.
The authors transfer all copyright ownership of the abstract to the ISBD 2014
The Scientific Program Committee reserves the right to determine the format of presentation (free paper or poster).
The authors agree to confine their presentation to the topic in the abstract.
The presenting author should attend the Congress to present the abstract if selected for the program.
The presenting author should immediately notify the ISBD Scientific Program Committee if he/she is unable to make a presentation or if the presenting author must be changed.
The authors guarantee that clinical studies and any animal tests have proceeded with the official approval by the relevant institutional review board, and any other relevant authorities.
Abstracts will be reviewed for their structure, content, perceived value to registrants in the IOIS and degree of innovation. All decisions are final.
Presenters at the ICBD 2014 (including poster session presenters) will be required to disclose any financial interests related to the presentations. Disclosure information must be submitted when an abstract is submitted on the website.